Published August 21, 2023 | Version v1
Other Open

Tirzepatide in Hispanic/Latino Patients with Type 2 Diabetes: A Subgroup Analysis of the SURPASS Program

  • 1. Velocity Clinical Research
  • 2. University of Miami Miller School of Medicine
  • 3. TechData Service
  • 4. Eli Lilly and Company

Description

This file contains the supplemental information for the paper, Tirzepatide in Hispanic/Latino Patients with Type 2 Diabetes: A Subgroup Analysis of the SURPASS Program, by Frias, JP, et al.

Files